Pro Dex (PDEX) Total Non-Current Liabilities (2013 - 2026)
Pro Dex (PDEX) posted Total Non-Current Liabilities of $15.1 million for Q1 2026, up 79.76% sequentially from $8.4 million in Q4 2025, and up 41.87% YoY from $10.7 million in Q1 2025.
Pro Dex (PDEX) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
Pro Dex has reported Total Non-Current Liabilities for 11 years, with the latest figure at $15.1 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 41.87% year-over-year to $15.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.1 million (up 41.87% YoY) and the FY2025 annual result came in at $9.9 million, up 13.91% from the prior year.
- Total Non-Current Liabilities climbed to $15.1 million in Q1 2026 per PDEX's latest filing, from $8.4 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $15.1 million in Q1 2026 and troughed at $8.4 million in Q4 2025.
- A 5-year average of $10.9 million and a median of $10.7 million in 2025 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2025 and 2026: Total Non-Current Liabilities slipped 26.19% in 2025, then surged 41.87% in 2026.
- Over 5 years, Total Non-Current Liabilities stood at $11.4 million in 2022, then retreated by 15.64% to $9.7 million in 2023, then advanced by 18.26% to $11.4 million in 2024, then decreased by 26.19% to $8.4 million in 2025, then soared by 79.76% to $15.1 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $15.1 million, $8.4 million, and $9.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.51 Bn | 127.30 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 51.76 Bn | 50.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.39 Bn | 34.04 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.45 Bn | 31.98 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 28.29 Bn | 25.61 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 24.92 Bn | 24.49 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.28 Bn | 14.88 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.77 Bn | 14.63 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.51 Bn | 11.36 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Pro Dex | 208.85 Mn | 197.87 Mn | 6.13 Mn | 15.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.14 Mn |
| Dec 31, 2025 | 8.42 Mn |
| Sep 30, 2025 | 9.18 Mn |
| Jun 30, 2025 | 9.93 Mn |
| Mar 31, 2025 | 10.67 Mn |
| Dec 31, 2024 | 11.41 Mn |
| Sep 30, 2024 | 12.15 Mn |
| Jun 30, 2024 | 8.72 Mn |
| Mar 31, 2024 | 9.19 Mn |
| Dec 31, 2023 | 9.65 Mn |
| Sep 30, 2023 | 10.11 Mn |
| Jun 30, 2023 | 10.56 Mn |
| Mar 31, 2023 | 10.99 Mn |
| Dec 31, 2022 | 11.44 Mn |
| Sep 30, 2022 | 11.88 Mn |
| Jun 30, 2022 | 12.30 Mn |
| Mar 31, 2022 | 13.89 Mn |
| Dec 31, 2021 | 14.14 Mn |
| Sep 30, 2021 | 14.27 Mn |
| Jun 30, 2021 | 13.97 Mn |